‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

Lenacapavir, a new HIV prevention injectable drug. The medication is already in use a a treatment for people living with the virus. Photograph: Nardus Engelbrecht/AP

A drug with the potential to “end the HIV pandemic” will launch in the US this week – as a new study reveals it could be sold for 1,000 times less than its possible price tag.

Lenacapavir, given as a twice-yearly injection, can prevent someone from being infected with HIV, according to clinical trial results.